Tofacitinib, An Oral Janus Kinase Inhibitor: Patient Reported Outcomes in An Australian Phase 3 Rheumatoid Arthritis Study Population
2013
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
3
Citations
NaN
KQI